Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 2

Conditions

Keratosis, Actinic 2Bowen's Disease 1

Interventions

3-ingenyl angelate 39Imiquimod 22Aminolevulinic Acid 22Photochemotherapy 16methyl 5-aminolevulinate 12Fluorouracil 11Diclofenac 11Gels 10Cryotherapy 6Solutions 5BF-200 ALA 5tirbanibulin 4Radiotherapy 4Prilocaine 4Lidocaine 4LEO 43204 4Petrolatum 3Ointments 3Cryosurgery 3calcipotriene 2SR-T100 2Niacinamide 2Blue Light 21-phenyl-3,3-dimethyltriazene 2tazarotene 1potassium dobesilate 1perillyl alcohol 1endonuclease V, phage T4 1dexpanthenol 1cetyl alcohol, propylene glycol, sodium lauryl sulfate non-lipid cleansing lotion 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Keratosis, Actinic × SR-T100 × Clear all
NCT01516515 2018-12-05

Efficacy and Safety Phase II Study of SR-T100 to Treat Actinic Keratosis

G&E Herbal Biotechnology Co., LTD

Phase 2 Completed
86 enrolled
Dermatologic

Keratosis, Actinic

NCT02085395 2014-03-14

AK

G&E Herbal Biotechnology Co., LTD

Phase 2 Completed
27 enrolled
Dermatologic

Bowen's Disease, Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡